CAMBRIDGE, Mass., Aug. 7 /EMWNews/ -- Verenium Corporation

(Nasdaq: VRNM), a leading developer of cellulosic ethanol technology and a

pioneer in the development of high-performance specialty enzymes, announced

today that Gerald M. Haines II, Executive Vice President, will present at

the upcoming Canaccord Adams 28th Annual Global Growth Conference. The

presentation is scheduled to begin at 10:30 a.m. ET on Thursday, August 14,

and will take place at the InterContinental Hotel in Boston.



    More information about this event, including a live webcast, may be

accessed by visiting the "Investors" section of Verenium's website at

http://www.verenium.com. A webcast replay will be available approximately

one hour after the live webcast ends and will be accessible for one month

following the conference.

    About Verenium



    Verenium Corporation is a leader in the development and

commercialization of cellulosic ethanol, an environmentally-friendly and

renewable transportation fuel, as well as high-performance specialty

enzymes for applications within the biofuels, industrial, and health and

nutrition markets. The Company possesses integrated, end-to-end

capabilities in pre-treatment, novel enzyme development, fermentation,

engineering, and project development and is moving rapidly to commercialize

its proprietary technology for the production of ethanol from a wide array

of feedstocks, including sugarcane bagasse, dedicated energy crops,

agricultural waste, and wood products. In addition to the vast potential

for biofuels, a multitude of large-scale industrial opportunities exist for

the Company for products derived from the production of low-cost,

biomass-derived sugars.



    Verenium's Specialty Enzyme business harnesses the power of enzymes to

create a broad range of specialty products to meet high-value commercial

needs. Verenium's world class R&D organization is renowned for its

capabilities in the rapid screening, identification, and expression of

enzymes-proteins that act as the catalysts of biochemical reactions. For

more information on Verenium, visit http://www.verenium.com.



    Forward Looking Statements



    Statements in this press release that are not strictly historical are

"forward-looking" and involve a high degree of risk and uncertainty. These

include statements related to the Company's operations, capabilities,

commercialization activities, target markets and cellulosic ethanol

facilities, all of which are prospective. Such statements are only

predictions, and actual events or results may differ materially from those

projected in such forward-looking statements. Factors that could cause or

contribute to the differences include, but are not limited to, risks

associated with Verenium's new and uncertain technologies, risks associated

with the costs, labor requirements and labor availability associated with

Verenium's demonstration plant, risks associated with Verenium's ability to

obtain additional capital to support its planned operations, risks

associated with Verenium's dependence on patents and proprietary rights,

risks associated with Verenium's protection and enforcement of its patents

and proprietary rights, technological, regulatory, competitive and other

risks related to development, production, and commercialization of

cellulosic ethanol and other biofuels and the commercial prospects of those

industries, Verenium's dependence on existing collaboration, manufacturing,

and/or license agreements, and its ability to achieve milestones under

existing and future collaboration agreements, the ability of Verenium and

its partners to commercialize products (including by obtaining any required

regulatory approvals) using Verenium's technologies and timing for

launching any commercialized products, the ability of Verenium and its

collaborators to market and sell any products that it or they

commercialize, the development or availability of competitive products or

technologies, the future ability of Verenium to enter into and/or maintain

collaboration and joint venture agreements and licenses, changes in the

U.S. or global energy markets and laws and regulations applicable to them,

and risks and other uncertainties more fully described in the Company's

filings with the Securities and Exchange Commission, including, but not

limited to, the Company's quarterly report on Form 10-Q for the three

months ended June 30, 2008. These forward-looking statements speak only as

of the date hereof. The Company expressly disclaims any intent or

obligation to update these forward-looking statements.






     Contact:

     Verenium Corporation

     Sarah Carmody

     Sr. Corporate Communications Associate

     617-674-5357

     [email protected]